Capricor Therapeutics (CAPR) announced the appointment of Michael Binks, M.D., as Chief Medical Officer, effective immediately. Dr. Binks brings 25 years of experience leading global clinical development and translational research across the pharmaceutical and biotechnology sectors.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAPR:
- Capricor Therapeutics, Inc. (CAPR) Q1 Earnings Cheat Sheet
- Capricor FDA panel meeting ‘not unexpected,’ says JonesResearch
- Capricor share weakness unwarranted, says H.C. Wainwright
- Capricor completes mid-cycle review with FDA for BLA for deramiocel
- Vaccine, gene therapy makers fall after Peter Marks resignation